USANA Health Sciences(USNA) - 2026 Q4 - Annual Report

Regulatory and Compliance Risks - Direct selling is subject to intense government scrutiny, and changes in laws or regulations could adversely affect the company's business [177]. - The company is subject to various governmental export control and trade sanctions laws that could impair its ability to compete in international markets [171]. - The company is subject to extensive government regulation regarding its products and manufacturing activities, which could limit or prevent sales in some markets [171]. - The company has faced legal actions and regulatory scrutiny regarding misleading product claims and earnings representations, which could lead to significant fines and operational changes [178]. - The company has faced regulatory challenges in various markets, including China, India, South Korea, Malaysia, and Indonesia, requiring modifications to its Compensation Plan to comply with local laws [190]. - The Chinese government has imposed significant fines on companies violating direct selling regulations, which could adversely affect the company's operations in China [201]. - The company must obtain direct selling licenses from municipalities and provinces in China to expand its business, with the application review process currently suspended since 2019 [203]. - The company’s operations in China are subject to evolving government regulations, which could materially harm its business if compliance is not maintained [194]. - Compliance with environmental laws and regulations may require substantial expenditures, potentially affecting financial condition and operations [221]. - Compliance with anti-corruption laws, including the U.S. Foreign Corrupt Practices Act, is critical as the company expands internationally, with potential severe penalties for violations [234][236]. Financial Performance and Market Conditions - The Greater China region accounts for a significant part of the company's business and expected growth, and a decline in sales or customers in this region would harm its financial condition [171]. - Economic conditions have negatively impacted sales and profitability, with ongoing uncertainty regarding future market conditions [274]. - The effective tax rate has significantly increased over the past few years and is expected to remain elevated due to a geographic misalignment between 76% of net sales generated outside the U.S. and the majority of operating expenses incurred in the U.S. [239]. - The effective tax rate may continue to exceed historical levels if the company cannot diversify income geographically or implement compliant cross-border tax planning strategies [241]. - The company is exposed to foreign currency risks due to a significant portion of sales generated outside the United States, which can affect sales and earnings [381]. Operational Challenges - The company may incur obligations relating to the activities of its Brand Partners, including potential reclassification of independent contractors to employees, which could impose additional financial responsibilities [186]. - The company has experienced adverse publicity related to enforcement of Brand Partner policies, making it difficult to attract and retain Brand Partners and Preferred Customers [185]. - The company has experienced temporary shortages of raw materials, leading to higher prices that negatively impacted gross margins [225]. - Delays and disruptions in transportation and distribution have resulted in increased costs and could negatively impact profitability [226]. - The company may face challenges in integrating acquired businesses, which could lead to unexpected costs and operational disruptions [266]. Strategic Initiatives and Acquisitions - The Hiya Acquisition may not be accretive to earnings per share and could result in additional costs and expenses, negatively affecting the market price of the company's common stock [176]. - The Hiya Acquisition was completed in December 2024, with integration activities expected to continue into 2025, potentially disrupting ongoing business [264]. - The company anticipates synergies from the Hiya Acquisition, but integration challenges may delay or prevent realization of these benefits [263]. - In 2023, the company launched an Affiliate program in certain markets, modifying its Brand Partner Compensation Plan to enhance earning opportunities [189]. Market Competition and Customer Dynamics - The company faces intense competition in the nutritional supplement market, with the need to adopt AI technology to maintain its competitive position [278]. - The company relies on Brand Partners and Preferred Customers for sales growth, with a noted decline in active Customers in several markets, including China [256]. - Rise's business is heavily dependent on a limited number of key retail customers, and any loss or reduction in orders could materially affect its financial condition [271]. - Adverse publicity and negative public perception regarding direct selling and product efficacy could harm the company's reputation and financial results [275]. Risk Management and Security - The company faces risks related to data security and privacy, including potential breaches that could lead to significant liabilities and damage to reputation [248][249]. - The company has implemented a business continuity and disaster recovery plan to mitigate risks associated with information technology systems, but vulnerabilities remain [247]. - The company has incurred substantial costs to comply with various data privacy and security laws, which may limit its ability to provide valuable products and services [255]. - The company is encountering an expanded risk landscape due to the use of artificial intelligence technologies, which may impact data security and compliance with evolving regulations [251]. Manufacturing and Supply Chain - Approximately 56% of the products sold to customers are manufactured in-house, with an increased focus on self-manufacturing of foods, personal care, and skincare products [220]. - 44% of product sales for the year ended January 3, 2026, were from third-party suppliers and manufacturers [222]. - Inflationary pressures and rising costs of commodities and raw materials could adversely affect profitability, as the company may not be able to pass all costs onto customers [216]. - The company has implemented strategies to mitigate currency fluctuation risks, including timely repatriation of earnings and entering into currency exchange contracts [215][382]. Ownership and Governance - Gull Global, Ltd., owned by founder Dr. Myron Wentz, held approximately 40.0% of the outstanding common stock as of January 3, 2026, giving him significant influence over company affairs [283]. - The concentration of stock ownership may delay or deter beneficial changes in control, potentially impacting shareholder interests [283]. - The company’s ability to protect its intellectual property is limited, as most products are not patent-protected, relying instead on trade secret laws [280].